Defence Therapeutics Inc. (CSE:DTC)
Canada flag Canada · Delayed Price · Currency is CAD
0.5000
0.00 (0.00%)
Jun 10, 2026, 9:35 AM EST

COSE:PKME.N0000 Income Statement

Millions CAD. Fiscal year is Jul - Jun.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Selling, General & Admin
1.881.522.962.63.141.06
Research & Development
1.50.83.863.583.761.16
Amortization of Goodwill & Intangibles
--0.040.01--
Operating Expenses
3.793.1912.756.497.272.83
Operating Income
-3.79-3.19-12.75-6.49-7.27-2.83
Interest Expense
-0.29-0.32-0.4-0.26--
Interest & Investment Income
000.020.01--
Currency Exchange Gain (Loss)
0.04-0.010-0.07-0.02-
Other Non Operating Income (Expenses)
-2.25-0.08-0.08-0.05-0.05-0.03
EBT Excluding Unusual Items
-6.28-3.6-13.19-6.87-7.34-2.86
Other Unusual Items
0.230.08----
Pretax Income
-6.05-3.52-13.19-6.87-7.34-2.86
Income Tax Expense
----0.11--
Net Income
-6.05-3.52-13.19-6.76-7.34-2.86
Net Income to Common
-6.05-3.52-13.19-6.76-7.34-2.86
Shares Outstanding (Basic)
605045403627
Shares Outstanding (Diluted)
605045403627
Shares Change (YoY)
34.05%11.64%12.54%9.93%35.65%2719.76%
EPS (Basic)
-0.10-0.07-0.30-0.17-0.20-0.11
EPS (Diluted)
-0.10-0.07-0.30-0.17-0.20-0.11
Free Cash Flow
-4.55-3.4-4.49-7.72-6.04-2.29
Free Cash Flow Per Share
-0.08-0.07-0.10-0.20-0.17-0.09
EBITDA
-3.76-3.14-12.68-6.48--
D&A For EBITDA
0.020.050.070.01--
EBIT
-3.79-3.19-12.75-6.49-7.27-2.83
Advertising Expenses
-0.531.711.962.52-